Covered recipient · General Payments record
XINTONG LI
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2020–2024
$1,590.80
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $353.72 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $101.06 | 4 |
| Apellis Pharmaceuticals, Inc. | $100.14 | 1 |
| GLAUKOS CORPORATION | $56.97 | 2 |
| Oyster Point Pharma, Inc. | $33.64 | 2 |
| RxSight Inc | $25.42 | 1 |
| BIOTISSUE HOLDINGS INC. | $22.22 | 1 |
| Tarsus Pharmaceuticals, Inc. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $26.76 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115870345 | CMS |
| Amgen Inc. | $24.81 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115870356 | CMS |
| Amgen Inc. | $25.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115870364 | CMS |
| Amgen Inc. | $24.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115870373 | CMS |
| Apellis Pharmaceuticals, Inc. | $100.14 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154031481 | CMS |
| BIOTISSUE HOLDINGS INC. | $22.22 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148774971 | CMS |
| Glaukos Corporation | $40.92 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985882 | CMS |
| Glaukos Corporation | $16.05 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985880 | CMS |
| Oyster Point Pharma, Inc. | $17.53 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147419078 | CMS |
| Oyster Point Pharma, Inc. | $16.11 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147437955 | CMS |
| RxSight Inc | $25.42 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144220852 | CMS |
| Tarsus Pharmaceuticals, Inc. | $14.27 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139112289 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.